Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2021 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces the Initial Dosing of the First Patient in the U.S. Phase 1 Clinical Trial of ON 123300

NEWTOWN, Pa., May 21, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
May 20, 2021 08:32 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Reverse Stock Split and Decrease in Authorized Shares

NEWTOWN, Pa., May 20, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq: ONTX) (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and...
May 17, 2021 16:05 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update

Conference call and live webcast at 4:30 p.m. ET today NEWTOWN, Pa., May 17, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a clinical-stage biopharmaceutical...
May 10, 2021 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2021 Financial Results on May 17, 2021

NEWTOWN, Pa., May 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
April 22, 2021 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Announces First Patient Dosed in Investigator-Initiated Phase 2 Study of Rigosertib in Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma

NEWTOWN, Pa., April 22, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
April 01, 2021 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Enrollment in Second Cohort of Phase 1 Study with ON 123300 in China

NEWTOWN, Pa., April 01, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
March 29, 2021 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova to Present at the Spring 2021 Oncology Investor Conference

NEWTOWN, Pa., March 29, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
March 11, 2021 16:05 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics Reports Full Year 2020 Financial Results, Provides Business Update

Conference call begins at 4:30 p.m. Eastern time today NEWTOWN, Pa., March 11, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a clinical-stage biopharmaceutical...
March 04, 2021 16:15 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Provide Corporate Update and Full Year 2020 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time on Thursday, March 11, 2021 NEWTOWN, Pa., March 04, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a...
March 01, 2021 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Participate in Three Investment Conferences During the Month of March

NEWTOWN, PA., March 01, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products for...